Dashboard
Manage Tickers

XGN


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

btig-maintains-buy-on-exagen-raises-price-target-to-15
BTIG Maintains Buy on Exagen, Raises Price...
11/10/2025 11:51:29

BTIG analyst Mark Massaro maintains Exagen (NASDAQ:XGN) with a Buy and raises the price target from $13 to $15.

b-riley-securities-reiterates-buy-on-exagen-raises-price-target-to-18
B. Riley Securities Reiterates Buy on Exag...
11/05/2025 17:26:21

B. Riley Securities analyst Anderson Schock reiterates Exagen (NASDAQ:XGN) with a Buy and raises the price target from $15 t...

correction-exagen-q3-adj-eps-019-misses-016-estimate-sales-17244m-beat-16895m-estimate
CORRECTION: Exagen Q3 Adj. EPS $(0.19) Mis...
11/04/2025 14:38:00

Exagen (NASDAQ:XGN) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.16) by 20...

exagen-affirms-fy2025-sales-guidance-of-65000m-70000m-vs-67487m-est
Exagen Affirms FY2025 Sales Guidance of $6...
11/04/2025 13:02:40

Exagen (NASDAQ:XGN) affirms FY2025 sales outlook from $65.000 million-$70.000 million to $65.000 million-$70.000 million vs $67...

earnings-scheduled-for-november-4-2025
Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

booking-holdings-to-rally-around-12-here-are-10-top-analyst-forecasts-for-monday
Booking Holdings To Rally Around 12%? Here...
10/27/2025 12:00:54

canaccord-genuity-maintains-buy-on-exagen-raises-price-target-to-15
Canaccord Genuity Maintains Buy on Exagen,...
10/27/2025 11:32:13

Canaccord Genuity analyst Kyle Mikson maintains Exagen (NASDAQ:XGN) with a Buy and raises the price target from $11 to $15.

demystifying-exagen-insights-from-5-analyst-reviews
Demystifying Exagen: Insights From 5 Analy...
10/22/2025 14:00:46

btig-maintains-buy-on-exagen-raises-price-target-to-13
BTIG Maintains Buy on Exagen, Raises Price...
10/22/2025 12:05:45

BTIG analyst Mark Massaro maintains Exagen (NASDAQ:XGN) with a Buy and raises the price target from $11 to $13.

keybanc-maintains-overweight-on-exagen-raises-price-target-to-15
Keybanc Maintains Overweight on Exagen, Ra...
10/14/2025 13:46:07

Keybanc analyst Paul Knight maintains Exagen (NASDAQ:XGN) with a Overweight and raises the price target from $12 to $15.

beyond-the-numbers-4-analysts-discuss-exagen-stock
Beyond The Numbers: 4 Analysts Discuss Exa...
09/11/2025 12:02:30

b-riley-securities-initiates-coverage-on-exagen-with-buy-rating-announces-price-target-of-15
B. Riley Securities Initiates Coverage On ...
09/11/2025 11:32:51

B. Riley Securities analyst Anderson Schock initiates coverage on Exagen (NASDAQ:XGN) with a Buy rating and announces Price ...

canaccord-genuity-maintains-buy-on-exagen-raises-price-target-to-11
Canaccord Genuity Maintains Buy on Exagen,...
07/30/2025 12:22:22

Canaccord Genuity analyst Kyle Mikson maintains Exagen (NASDAQ:XGN) with a Buy and raises the price target from $8 to $11.

what-analysts-are-saying-about-exagen-stock
What Analysts Are Saying About Exagen Stock
07/30/2025 12:00:38

keybanc-upgrades-exagen-to-overweight-maintains-price-target-to-12
Keybanc Upgrades Exagen to Overweight, Mai...
07/30/2025 11:02:43

Keybanc analyst Paul Knight upgrades Exagen (NASDAQ:XGN) from Sector Weight to Overweight and maintains the price target fro...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/29/2025 17:06:19

exagen-sees-fy2025-sales-65000m-70000m-vs-65515m-est
Exagen Sees FY2025 Sales $65.000M-$70.000M...
07/29/2025 13:10:44

Exagen (NASDAQ:XGN) sees FY2025 sales of $65.000 million-$70.000 million vs $65.515 million analyst estimate.

exagen-q2-adj-eps-018-misses-014-estimate-sales-17202m-beat-16233m-estimate
Exagen Q2 Adj. EPS $(0.18) Misses $(0.14) ...
07/29/2025 12:06:20

Exagen (NASDAQ:XGN) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.14) by 28...

Core News & Articles
Earnings Scheduled For July 29, 2025
07/29/2025 08:32:31

craig-hallum-initiates-coverage-on-exagen-with-buy-rating-announces-price-target-of-12
Craig-Hallum Initiates Coverage On Exagen ...
07/23/2025 18:14:01

Craig-Hallum analyst John Wilkin initiates coverage on Exagen (NASDAQ:XGN) with a Buy rating and announces Price Target of $12.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION